VistaGen Therapeutics, Inc.

VistaGen Therapeutics, Inc.

VTGN
VistaGen Therapeutics, Inc.US flagNASDAQ Capital Market
0.56
USD
-0.02
- -
18.36MMarket Cap

VistaGen Therapeutics, Inc. (VTGN) Stock Splits

Learn about VistaGen Therapeutics, Inc.'s most recent 1-for-30 basis stock split on June 07, 2023. Understand the impact on shareholders and the company's market position.

Latest Stock Split Details

Key information about VistaGen Therapeutics, Inc.'s most recent stock split

Split Date: 2023-06-07
Split Ratio: 1:30
Price Before Split: $0.09
Price After Split: $0.00

Impact of the Stock Split

Understanding what this means for shareholders

  • The total value of your investment remains the same
  • You now own 30.00 times fewer shares (a 1:30 ratio)
  • The price per share is increased proportionally

Historical Stock Splits

A comprehensive history of VistaGen Therapeutics, Inc.'s stock splits

DateRatioIs Reverse SplitPrice Before SplitPrice After Split
2023-06-071:30Yes$0.09$0.00
2014-08-141:20Yes$0.60$0.03

About VistaGen Therapeutics, Inc.

Company overview and industry information

VistaGen Therapeutics, Inc. (VTGN) operates in the Biotechnology industry. The recent 1-for-30 reverse stock split is part of the company's strategy to adjust its share price and potentially meet stock exchange listing requirements.

Biotechnology
Go to VistaGen Therapeutics, Inc. Summary

Last updated: 6/4/2026

This information is for educational purposes only. Always consult with a financial advisor before making investment decisions.